HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

5,10-Methenyltetrahydrofolate synthetase activity is increased in tumors and modifies the efficacy of antipurine LY309887.

Abstract
Methenyltetrahydrofolate synthetase (MTHFS) expression enhances folate-dependent de novo purine biosynthesis. In this study, the effect of increased MTHFS expression on the efficacy of the glycinamide ribonucleotide formyltransferase (GARFT) inhibitor LY309887 was investigated in SH-SY5Y neuroblastoma. GARFT catalyzes the incorporation of formate, in the form of 10-formyltetrahydrofolate, into the C8 position of the purine ring during de novo purine biosynthesis. SH-SY5Y neuroblastoma with increased MTHFS expression displayed a 4-fold resistance to the GARFT inhibitor LY309887, but did not exhibit resistance to the thymidylate synthase inhibitor Pemetrexed. This finding supports a mechanism whereby MTHFS increases the availability of 10-formyltetrahydrofolate for GARFT. MTHFS expression is elevated in animal tumor tissues compared to surrounding normal tissue, consistent with the dependence of transformed cells on de novo purine biosynthesis. The level of MTHFS expression in tumors may predict the efficacy of antipurine agents that target GARFT.
AuthorsMartha S Field, Montserrat C Anguera, Rodney Page, Patrick J Stover
JournalArchives of biochemistry and biophysics (Arch Biochem Biophys) Vol. 481 Issue 2 Pg. 145-50 (Jan 15 2009) ISSN: 1096-0384 [Electronic] United States
PMID19022216 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • 6R-2',5'-thienyl-5,10-dideazatetrahydrofolic acid
  • Antineoplastic Agents
  • DNA, Complementary
  • Tetrahydrofolates
  • Carbon-Nitrogen Ligases
  • 5,10-methenyltetrahydrofolate synthetase
Topics
  • Animals
  • Antineoplastic Agents (pharmacology, therapeutic use)
  • Biopsy
  • Carbon-Nitrogen Ligases (drug effects, genetics, metabolism)
  • Cats
  • DNA, Complementary (genetics)
  • Dogs
  • Humans
  • Mice
  • Mice, Transgenic
  • Neuroblastoma (drug therapy, enzymology, pathology)
  • Tetrahydrofolates (pharmacology)
  • Transplantation, Heterologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: